Dr. Klas Udekwu

Dr. Klas Udekwu

Assistant Professor

Karolinska Institute, Department of Neuroscience
Uppsala, Sweden

plus Speciality



Name: UDEKWU Klas I, PhD E-mail: klas.udekwu@ki.se Education (in reverse chronological order) 1. 2002/06/01 to 2007/06/01: PhD studies; Institute of Cell & Molecular Biology, Uppsala University Sweden. 2. 1998/09 to 2002/01: Masters education, Institute for biological education (IBG), Uppsala university, Sweden. 3. 2007/06/01 to 2010/06/06: Postdoctoral Fellow, Emory University, Atlanta, USA 4. 2010/06/08 to 2010/12/08: senior Postdoctoral Researcher Uppsala University Department of Cell and Molecular Biology. Diarmaid Hughes group, Swedish Research council fellowship 5. 2010/12/09 to 2011/08/31: Senior Postdoctoral Researcher / Independent Group Leader, Karolinska Institute Department of Neuroscience. Agneta Richter-Dahlfors group 6. 2011/09/01 to present: Assistant Professor, Karolinska Institute, Department of Neuroscience

Academic positions:

Work and related activity 1. 2012-present: Boardmember Karolinska Institutet’s Junior Faculty Steering Committee. 2. 1998–2000: Boardmember FiF (Flogsta student tenant organization in Uppsala, 5000 tenants) 3. 1999–2000: Chairman FiF. 4. 1998-1999: Personal assistant for mentally handicapped, Uppsala county. Positions held 1. Assistant Professor (Forskarassistent), Karolinska Institutet, Department of Neuroscience (Competitive). 2011-09-01 until 2015-08-31. 2. Assistant Professor (Forskarassistent), Umeå University, Faculty of Medicine (Competitive). 2011-04-01 DECLINED Conferences attended/ presentations 1. 2001:June;Rnomics, the functional genomics of RNA. Stockholm. 2. 2002 (i)January; Non-coding RNA, Aussois, France (POSTER presentation). (ii)June; Rnomics, the functional genomics of RNA. Stockholm, Sweden (ORAL presentation). (iii)August; Structure and function of non-coding RNAs, Sandhamn, Sweden (workshop). (iv)December; 2nd Swedish Proteomics Society Symposium. Lund, Sweden. 3. 2004: October NorFa RNA network. Bergen, Norway (ORAL presentation). 4. 2005 (i)May; RNA 2005. Banff, Canada (POSTER presentation). (ii)September; FOSRAK-meeting. Kassel, Tyskland (ORAL presentation). 5. 2006: June; RNA 2006. Seattle, U.S.A (ORAL presentation). 6. 2006: June; Emory university. Atlanta, U.S.A. (Invited speaker). 7. 2007: October; EEID meeting. Albuquerque, NM, U.S.A. (ORAL presentation) 8. 2008: May; Uppsala university. Sweden (ORAL presentation) 9. 2009: February; RFF consultation on Staphylococcus aureus community-acquired infections. Jacksonville, FL, USA (Invited consultation) 10. 2009: July; Gordon Research Conference on Microbial Population Biology, New Hampshire, U.S.A. (POSTER presentation) 11. 2009: October; ESCMID Conference on Antibiotic Treatment Failure in the Absence of Bacterial Resistance, Freiburg, Germany (Invited speaker) 12. 2009: July; Mathematical Biology colloquium; Mathematical considerations of antibiotic treatment, Atlanta GA, USA (Invited speaker) 13. 2010: October; EMBO conference, (POSTER presentation) 14. 2011: March; Biomedical Engineering Seminar, Vanderbilt University, Nashville TN, USA (Guest Speaker) 15. 2011: May; Göteborg Biomaterials Research Forum, Gothenburg, Sweden (Attendee) 16. 2011: July; Gordon Research Conference on Microbial Population Biology, New Hampshire, U.S.A. (POSTER presentation) 17. 2011: August; DIMACS Workshop on Genetics and Disease Control, Cape Coast, Ghana (Invited Speaker)

Research interests:


Any other information:

Publications 1. Udekwu KI*, Levin BR. Staphylococcus aureus in continuous culture: a tool for the rational design of antibiotic treatment protocols. PLOS One. 2012; 7(7):e38866. doi:10.1371. Epub 2012 July 20. 2. Emilio Alarcón*, Udekwu KI*, Skog M, Polisetti N, Wickham A, Pacioni NL, Stamplecoskie KG, Gonzalez-Béjar M, Richter-Dahlfors A, Griffith M, & Scaiano JC Silver Nanoparticles stabilized with Collagen type-I or ?-Poly-L-Lysine: Toward a rational design of a new biomaterial for biomedical applications. Biomaterials. 2012; 33(19):4947-56. Epub 2012 Apr 10. 3. Choong XC, Regberg J, Udekwu KI, Richter-Dahlfors A Intravital Models of Infection Lay the Foundation for Tissue Microbiology Future Microbiology. 2012; 7(4):519-33. 4. Nielsen KL, Pedersen TM, Udekwu KI, Petersen A, Skov RL , Hansen LH, Hughes DH and Frimodt-Møller N. Fitness cost: A Bacteriological Explanation for the Demise of the First International Methicillin-resistant Staphylococcus aureus Epidemic. J. Antimicrob. Chemo. 2012; 67(6):1325-32. Epub 2012 Feb 29. 5. Richter-Dahlfors A, Rhen M, Udekwu KI. Tissue Microbiology Provides a Coherent Picture of Infection. Curr. Opin. Microbiol. 2012; 15(1):15-22. PMID: 22070968 6. Altincicek B, ter Braak B, Laughton AM, Udekwu KI, Gerardo NM. Escherichia coli K-12 pathogenicity in the pea aphid, Acyrthosiphon pisum, reveals reduced antibacterial defense in aphids. Dev. Comp. Immunol. 2011; 35(10):1091-7. PMID: 21527277 7. Udekwu KI. Transcriptional and post-transcriptional regulation of the Escherichia coli luxS mRNA; involvement of the sRNA MicA. PLoS One. 2010; 5(10). PMID: 20976191. 8. Levin BR, Udekwu KI. The Population Dynamics of Antibiotic Treatment: A mathematical model and hypotheses for time-kill and continuous culture experiments. Antimicrob. Agents Chemo. 2010; 54(8): 3414-3426.PMID: 20516272 9. Udekwu KI, Parrish N, Ankomah P, Baquero F, Levin BR. Functional relationship between bacterial cell density and the efficacy of antibiotics. J. Antimicrob. Chemo. 2009; 63(4): 745-57. PMID: 19218572. Faculty 1000 (Recommended). 10. Udekwu KI & Wagner EG. Sigma E controls biogenesis of the antisense RNA MicA.Nucleic Acids Res. 2007; 35(4): 1279-88. PMID: 17267407. Faculty 1000 (Recommended). 11. Udekwu KI, Darfeuille F, Vogel J, Reimegard J, Holmqvist E, Wagner EG. Hfq-dependent regulation of OmpA synthesis is mediated by an antisense RNA.Genes Dev. 2005; 19(19): 2355-66. PMID: 16204185. Faculty 1000 (Must read).

What I think of the idea behind WebmedCentral and WebmedCentral plus: